Authors: Ulndreaj, Antigona^{j_cclm-2022-0471_aff_001}, Brinc, Davor^{j_cclm-2022-0471_aff_002}, Altan, Mehmet^{j_cclm-2022-0471_aff_003}, Pons-Belda, Oscar D.^{j_cclm-2022-0471_aff_001}, Fernandez-Uriarte, Amaia^{j_cclm-2022-0471_aff_001}, Mu-Mosley, Hong^{j_cclm-2022-0471_aff_004}, Fattah, Farjana^{j_cclm-2022-0471_aff_004}, von Itzstein, Mitchell S.^{j_cclm-2022-0471_aff_005}, Soosaipillai, Antoninus^{j_cclm-2022-0471_aff_006}, Kulasingam, Vathany^{j_cclm-2022-0471_aff_007}, Palaskas, Nicolas L.^{j_cclm-2022-0471_aff_008}, Gerber, David E.^{j_cclm-2022-0471_aff_009}, Diamandis, Eleftherios P.^{j_cclm-2022-0471_aff_007}, Heymach, John V.^{j_cclm-2022-0471_aff_003}, Prassas, Ioannis^{j_cclm-2022-0471_aff_006}

Superior Title: Clinical Chemistry and Laboratory Medicine (CCLM). 61(1):154-161

Availability: https://www.degruyter.com/document/doi/10.1515/cclm-2022-0471/html

Authors: von Itzstein, Mitchell S., Yuqiu Yang, Yiqing Wang, Hsiehchen, David, Sheffield, Thomas Y., Fattah, Farjana, Popat, Vinita, Ahmed, Murtaza, Homsi, Jade, Dowell, Jonathan E., Rashdan, Sawsan, Lohrey, Jay, Hammers, Hans J., Hughes, Randall S., Tao Wang, Yang Xie, Gerber, David E.

Superior Title: Frontiers in Immunology; 2024, p1-8, 8p

Subject Terms: DRUG side effects, ACNEIFORM eruptions, IMMUNE checkpoint inhibitors, IMMUNOTHERAPY, BIOMARKERS, FISHER exact test

Authors: von Itzstein, Mitchell S., Gonugunta, Amrit S., Wang, Yiqing, Sheffield, Thomas, Lu, Rong, Ali, Sadia, Fattah, Farjana J., Xie, Donglu, Cai, Jennifer, Xie, Yang, Gerber, David E.

Superior Title: Cancer Immunology, Immunotherapy; Sep2022, Vol. 71 Issue 9, p2169-2181, 13p

Subject Terms: LEVOTHYROXINE, IMMUNE checkpoint inhibitors, THYROID diseases, DRUG side effects, PROPORTIONAL hazards models, THYROTROPIN

Authors: Gonugunta, Amrit S., von Itzstein, Mitchell S., Gerber, David E.

Superior Title: Journal of Medical Case Reports; 7/24/2022, Vol. 16 Issue 1, p1-5, 5p

Subject Terms: NON-small-cell lung carcinoma, IMMUNE checkpoint inhibitors, CANCER chemotherapy, COMBINATION drug therapy, TREATMENT effectiveness

Authors: Hsiehchen, David, Naqash, Abdul Rafeh, Espinoza, Magdalena, Von Itzstein, Mitchell S., Cortellini, Alessio, Ricciuti, Biagio, Owen, Dwight H., Laharwal, Mehak, Yukihiro Toi, Burke, Michael, Yang Xie, Gerber, David E.

Superior Title: OncoImmunology; 2022, Vol. 11 Issue 1, p1-8, 8p

Subject Terms: DRUG side effects, TREATMENT effectiveness, IMMUNE checkpoint inhibitors, NON-small-cell lung carcinoma

Authors: von Itzstein, Mitchell S., Gonugunta, Amrit S., Mayo, Helen G., Minna, John D., Gerber, David E.

Superior Title: Cancer Journal; Nov/Dec2020, Vol. 26 Issue 6, p525-536, 12p

Authors: Khan, Shaheen¹ (AUTHOR) Shaheen.khan@utsouthwestern.edu, Gerber, David E.^1,2,3,4 (AUTHOR) David.Gerber@utsouthwestern.edu

Superior Title: Seminars in Cancer Biology. Aug2020, Vol. 64, p93-101. 9p.

Subject Terms: *IMMUNE checkpoint inhibitors, *TREATMENT effectiveness, *ADVERSE health care events, *AUTOIMMUNITY, *IMMUNE system

Authors: von Itzstein, Mitchell S., Gonugunta, Amrit S., Wang, Yiqing, Sheffield, Thomas, Lu, Rong, Ali, Sadia, Fattah, Farjana J., Xie, Donglu, Cai, Jennifer, Xie, Yang, Gerber, David E.

Superior Title: Cancer Immunology, Immunotherapy; Sep2022, Vol. 71 Issue 9, p2183-2184, 2p

Subject Terms: IMMUNE checkpoint inhibitors, IPILIMUMAB, THYROID diseases, WEB portals

Authors: Mohamad, Osama, Diaz de Leon, Alberto, Schroeder, Samuel, Leiker, Andrew, Christie, Alana, Zhang-Velten, Elizabeth, Trivedi, Lakshya, Khan, Saad, Desai, Neil B, Laine, Aaron, Albuquerque, Kevin, Iyengar, Puneeth, Arriaga, Yull, Courtney, Kevin, Gerber, David E., Hammers, Hans, Choy, Hak, Timmerman, Robert, Brugarolas, James, Hannan, Raquibul

Superior Title: OncoImmunology; 2018, Vol. 7 Issue 7, p1-1, 1p

Subject Terms: CANCER radiotherapy, ADVERSE health care events, IPILIMUMAB

Authors: Leal, Ticiana¹ (AUTHOR) ticiana.a.leal@emory.edu, Kotecha, Rupesh² (AUTHOR), Ramlau, Rodryg³ (AUTHOR), Zhang, Li⁴ (AUTHOR), Milanowski, Janusz⁵ (AUTHOR), Cobo, Manuel⁶ (AUTHOR), Roubec, Jaromir⁷ (AUTHOR), Petruzelka, Lubos⁸ (AUTHOR), Havel, Libor⁹ (AUTHOR), Kalmadi, Sujith¹⁰ (AUTHOR), Ward, Jeffrey¹¹ (AUTHOR), Andric, Zoran¹² (AUTHOR), Berghmans, Thierry¹³ (AUTHOR), Gerber, David E¹⁴ (AUTHOR), Kloecker, Goetz¹⁵ (AUTHOR), Panikkar, Rajiv¹⁶ (AUTHOR), Aerts, Joachim¹⁷ (AUTHOR), Delmonte, Angelo¹⁸ (AUTHOR), Pless, Miklos¹⁹ (AUTHOR), Greil, Richard^20,21,22 (AUTHOR)

Superior Title: Lancet Oncology. Sep2023, Vol. 24 Issue 9, p1002-1017. 16p.

Subject Terms: *NON-small-cell lung carcinoma, *ELECTRIC field therapy, *CANCER invasiveness, *IMMUNE checkpoint inhibitors, *METASTASIS, *ELECTROPORATION

Authors: Popat, Vinita

Contributors: Gerber, David E., Ariizumi, Kiyoshi, Minna, John D., Khan, Saad A.

Subject Terms: Immune Checkpoint Inhibitors, Lung Neoplasms, Retrospective Studies, Tumor Burden

File Description: application/pdf

Relation: https://hdl.handle.net/2152.5/9895

Availability: https://hdl.handle.net/2152.5/9895